<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">

News

Russia Expects COVID-19 Vaccine Approved by Mid-August

Read More

COVID-19 Vaccine Predicted by Q4 2020

Read More

Hundreds Given Coronavirus Vaccine in the UK

Read More

First Person in U.S. Receives Phase III COVID-19 Vaccine Shot

Read More

Intravacc and Celonic Will Develop and Produce a Novel COVID-19 Vaccine

Read More

Vaccine Developers Promise Diversity in Clinical Trials

Read More

Astrazeneca’s Coronavirus Vaccine Shows Positive Results

Read More

Pfizer and BioNTech Receive $2 Billion from U.S. Government for COVID-19 Vaccine

Read More

Synairgen Announces Positive Results in COVID-19 Clinical Trial

Read More

Decades-Old Blood Thinner May Double as a SARS-CoV-2 Cure

Read More

University of Pittsburgh Begins Recruiting Coronavirus Trial Participants

The University of Pittsburgh is in the process of recruiting 750 volunteers for coronavirus vaccine trials. Pittsburgh is one of 87 locations around the United States allocated as an official COVID-19 trial site. In addition to providing direct-to-patient services, Yourway can ship on the Next Flight Out (NFO) and charter private aircraft, including helicopters, or ensure point-to-point direct ground transportation in temperature controlled vehicles to ensure drug samples are received with a same day turnaround. We also offer 24/7 customer support and dispatch, so orders are fully accounted for at any time of day.

Read More

COVID-19 Trial Participants at the University of Emory Report Positive Results

Healthy volunteers at the University of Emory reported positive results in the phase II trial for a COVID-19 vaccine developed by Moderna in collaboration with the University of Cambridge. The vaccine produced a robust immune response and was well-tolerated with minimal side effects observed. With headquarters in the U.S., Yourway delivers full trial support and can easily access trial sites across the country.

Read More

AstraZeneca Pushes COVID-19 Vaccine Candidate Forward

AstraZeneca has partnered with the University of Oxford in hopes of producing a viable coronavirus vaccine candidate. Phase I clinical trial data is expected to be promising, though further trials around the world will be needed. With 21 strategically located global depots, Yourway is positioned to move trial supplies around the world within hours.

Read More

Gilead Starts Clinical Trial of Inhaled Remdesivir for Less-Severe COVID-19

Just two weeks after receiving approval from the FDA to begin testing an inhaled formulation of their remdesivir COVID-19 treatment, Gilead kicked off a trial comprised of 60 healthy participants. The drug, given in intravenous form has shown promise, but the effects of the inhaled dosage form targeting less severe cases are still unknown. Yourway offers end-to-end protection on shipment distribution and flexible options, including direct-to-patient services, to ensure drugs in trials reach their destinations as soon as possible.

Read More

Moderna’s COVID-19 Vaccine Triggers Immune Response

Read More
Media

Upcoming Events

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Global Clinical Trial Innovation, Challenges, and Perspectives

June 6, 2024
Yourway's EU Flagship Depot in Dublin, Ireland

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?